MRTX-1719 |
رقم الكتالوجGC63558 |
MRTX-1719 هو مثبط قوي فريد من نوعه وانتقائي لمجمع PRMT5 / MTA ، بتركيز IC50 أقل من 10 نانومتر في خلايا PRMT5 / MTA MTAPDEL SDMA.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2630904-45-7
Sample solution is provided at 25 µL, 10mM.
MRTX-1719 is a potent first-in-class selective inhibitor of the PRMT5/MTA complex, with an IC50 of less than 10 nM in PRMT5/MTA MTAPDEL SDMA cells[1]. MRTX-1719 is a molecule that specifically targets the PRMT5/MTA complex, essential for several cellular processes like regulating gene expression and remodeling chromatin. By inhibiting this complex, MRTX-1719 disrupts its role in maintaining cellular homeostasis, leading to potential therapeutic benefits in cancers where this pathway is dysregulated.
References:
[1]. Targeting the genetic and immunological drivers of cancer.
Cas No. | 2630904-45-7 | SDF | |
Formula | C23H18ClFN6O2 | M.Wt | 464.88 |
الذوبان | Storage | Store at -20°C | |
General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. |
Prepare stock solution | |||
![]() |
1 mg | 5 mg | 10 mg |
1 mM | 2.1511 mL | 10.7555 mL | 21.5109 mL |
5 mM | 0.4302 mL | 2.1511 mL | 4.3022 mL |
10 mM | 0.2151 mL | 1.0755 mL | 2.1511 mL |
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Average Rating: 5
(Based on Reviews and 3 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *